![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 29, 21969-21974, July 21, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Institut für Pharmakologie,
Universitätsklinikum Essen, D-45122 Essen, Germany
Received for publication, February 28, 2000, and in revised form, April 26, 2000
Most G protein-coupled receptors (GPCRs),
including the M1 muscarinic acetylcholine receptor
(mAChR), internalize in clathrin-coated vesicles, a process that
requires dynamin GTPase. The observation that some GPCRs like the
M2 mAChR and the angiotensin AT1A receptor (AT1AR) internalize irrespective of expression of
dominant-negative K44A dynamin has led to the proposal that
internalization of these GPCRs is dynamin-independent. Here, we report
that, contrary to what is postulated, internalization of M2
mAChR and AT1AR in HEK-293 cells is
dynamin-dependent. Expression of N272 dynamin, which lacks
the GTP-binding domain, or K535M dynamin, which is not stimulatable by
phosphatidylinositol 4,5-bisphosphate, strongly inhibits
internalization of M1 and M2 mAChRs and
AT1ARs. Expression of kinase-defective K298M c-Src or
Y231F,Y597F dynamin (which cannot be phosphorylated by c-Src) reduces
M1 mAChR internalization. Similarly, c-Src inhibitor PP1 as well as the generic tyrosine kinase inhibitor genistein strongly inhibit M1 mAChR internalization. In contrast,
M2 mAChR internalization is not (or is only slightly)
reduced by expression of these constructs or treatment with PP1 or
genistein. Thus, dynamin GTPases are not only essential for
M1 mAChR but also for M2 mAChR and
AT1AR internalization in HEK-293 cells. Our findings also
indicate that dynamin GTPases are differentially regulated by
c-Src-mediated tyrosine phosphorylation.
For most G protein-coupled receptors
(GPCRs),1 receptor
internalization is thought to be initiated by phosphorylation of the receptor by G protein-coupled receptor kinases and binding of the
cytosolic protein A large number of recent studies indicate that most GPCRs, including
M1, M3, and M4 muscarinic
acetylcholine receptors (mAChRs) in HEK-293 cells, internalize in
clathrin-coated vesicles in a dynamin-dependent manner.
This evidence is primarily based on the inhibitory effect of the
dominant-negative inhibitor of dynamin-mediated internalization, K44A
dynamin (10-13). In contrast, M2 mAChRs internalize in a
clathrin-independent manner and irrespective of expression of K44A
dynamin in HEK-293 cells (10, 12). Likewise, internalization of
angiotensin AT1A receptors (AT1ARs) (13),
dopamine D2 receptors (14), and secretin receptors (15) is
also insensitive to expression of K44A dynamin. This has led to
the proposal that internalization of these GPCRs is
dynamin-independent. However, in light of the notion that the binding
of GTP to dynamin probably involves binding to all three GTP- binding
motifs in the GTP-binding pocket, we reasoned that a dynamin mutant
lacking all three GTP-binding motifs might be a more appropriate
dominant negative dynamin mutant to determine whether internalization
of a particular GPCR is dynamin-dependent. Indeed, we here
demonstrate that internalization of M2 mAChR and AT1AR is strongly inhibited by expression of N272 dynamin,
which lacks the complete GTP-binding domain. Also, expression of K535M dynamin, which lacks PIP2-stimulated GTPase activity,
significantly blocks internalization of these GPCR species.
Materials--
N-[3H]Methylscopolamine
(82 Ci/mmol),
[125I]Tyr4-Sar1-Ile8-angiotensin
II (2200 Ci/mmol), and [ Cell Culture, Plasmid Construction, and DNA
Transfection--
HEK-293 tsA201 and HEK-293 cells were grown in
Dulbecco's modified Eagle's medium (DMEM)/F-12 medium supplemented
with 10% fetal calf serum, penicillin G (100 units/ml), and
streptomycin (100 µg/ml) in an atmosphere of 5% CO2.
Cells plated on 150-mm plates were transiently transfected with
mAChR/pCD-PS or AT1AR/pBC12BI DNA, together with one of the
vectors listed above as described before (10). For epitope tagging of
M2 mAChRs, the Myc sequence EQKLISEEDL was inserted after
the initiator methionine in the extracellular amino terminus of the
receptor by the polymerase chain reaction method with Pfu
DNA polymerase (Stratagene). The complete receptor DNA sequence was
verified by dideoxy DNA sequencing and subcloned in pcDNA3
(Invitrogen). Stably transfected HEK-293 cells expressing Myc-tagged
M2 mAChR were selected after culturing in medium containing
500 µg/ml G418 (Life Technologies, Inc.).
Immunoblot Analysis of c-Src and Dynamin
Expression--
Forty-eight hours after DNA transfection,
cells on 35-mm plates were washed twice with phosphate-buffered saline
(150 mM NaCl, 6.5 mM
Na2HPO4, 2.7 mM KCl, pH 7.4) and
lysed by the addition of 0.5 ml of boiling lysis buffer (1% SDS, 10 mM Tris-HCl, pH 7.4). Lysate was transferred to a
microcentrifuge tube and boiled for 5 min. After five passages through
a 25-gauge needle, samples were centrifuged for 5 min to remove
insoluble material and diluted to an equal amount of protein as
measured by the BCA method (Pierce) with lysis buffer. Fifty
microliters of electrophoresis sample buffer (250 mM
Tris-HCl, pH 6.8, 4% SDS, 10% glycerol, 0.006% bromphenol blue, 2%
2-mercaptoethanol) were added to 50 µl of the diluted samples and
boiled for another 5 min. After SDS-polyacrylamide gel electrophoresis
on 10% polyacrylamide gels, protein was blotted onto nitrocellulose.
Nitrocellulose was then blocked with 150 mM NaCl, 10 mM Tris-HCl, pH 7.5, containing 5% bovine serum albumin (BSA; fraction V; Sigma) (dynamin) or 5% skin milk (c-Src). After washing three times for 5 min in 150 mM NaCl, 10 mM Tris-HCl, pH 7.5, 0.1% Tween 20, the blot was incubated
with either anti-dynamin antibody (clone 41, 0.125 µg/ml; or C-16,
0.4 µg/ml) or anti-c-Src antibody N-16 (0.1 µg/ml) in blocking
buffer for 1 h. Following four washes for 5 min in wash buffer and
incubation in blotting buffer for 10 min, the blot was incubated with
horseradish peroxidase-conjugated goat anti-mouse antibody (0.2 µg/ml), horseradish peroxidase-conjugated rabbit anti-goat antibody
(diluted 1:1000), or horseradish peroxidase-conjugated goat
anti-rabbit antibody (diluted 1:1000) at room temperature. After 1 h, the blot was washed again, and immunoreactivity was visualized by
enhanced chemiluminescence (Amersham Pharmacia Biotech).
Immunocytochemical Localization of Myc-tagged M2
mAChR--
HEK-293 cells stably expressing Myc-tagged M2
mAChR at a density of 350 fmol/mg of protein and grown on
poly-L-lysine-coated 18 × 18-mm glass coverslips were
incubated in 25 mM HEPES-buffered DMEM/F-12 medium (pH 7.4)
in the presence and absence of 1 mM carbachol for 60 min.
Then cells were washed twice with phosphate-buffered saline, fixed, and
permeabilized in methanol for 5 min at 4 °C. Cells were washed three
times with phosphate-buffered saline for 5 min each and incubated in
TBS (10 mM Tris-HCl, pH 7.4, 150 mM NaCl)
containing 0.5% fatty acid-free BSA for 45 min at room temperature. After incubation with mouse anti-Myc 9E10 antibody (5 µg/ml) in TBS
plus 0.5% BSA for 60 min at room temperature, cells were washed three
times with TBS plus 0.5% BSA for 5 min each and subsequently incubated
with fluorescein isothiocyanate-labeled anti-mouse antibody (10 µg/ml) in TBS plus 0.5% BSA for 60 min at room temperature in the
dark. After three washes with TBS plus 0.5% BSA for 5 min each and
once in TBS for 5 min, coverslips were mounted using Moviol
(Calbiochem). Immunofluorescence was detected using a Zeiss Axiophot fluorescence microscope equipped with standard fluorescein filter. Immunofluorescence was marginal in nontransfected cells and
cells expressing wild-type M2 mAChRs (without Myc tag), as well as in Myc-tagged M2 mAChR-expressing cells when second
antibody without the first antibody was used.
Dynamin Immunoprecipitation--
HEK-293 cells on 150-mm plates
stably expressing M1 mAChRs (17) were serum-starved in
DMEM/F-12 medium. After 16 h, cells were preincubated in 25 mM HEPES-buffered DMEM/F-12 medium for 30 min and then
stimulated for 5 min with 100 µM carbachol. After rapid
suction of medium from the plates, 1.5 ml of ice-cold radioimmune precipitation assay buffer (10 mM Tris-HCl, pH 7.4, 10 mM EDTA, 500 mM NaCl, 1% Nonidet P-40, 0.1%
SDS, 0.5% deoxycholate, 20 mM NaF, 1 mM
NaVO4, 1 mM dithiothreitol, 2.5 µg/ml
leupeptin, 2.5 µg/ml aprotinin, 100 µM
phenylmethylsulfonyl fluoride) was added to the cell monolayer. After
10 min at 4 °C, cells were lysed by repeated aspiration through a
21-gauge and 25-gauge needle. The cell lysate was centrifuged at
14,000 × g for 10 min at 4 °C. The supernatant was
incubated with mouse anti-dynamin monoclonal antibody (3.75 µg) for
1 h at 4 °C followed by incubation with 50 µl of Protein G
Plus/Protein A-agarose beads (Calbiochem) for 2 h at 4 °C while
rotating. Then immunoprecipitates were collected by centrifugation at
14,000 × g at 4 °C. The pellets were washed five
times with ice-cold radioimmune precipitation buffer and once with
ice-cold buffer A (110 mM NaCl, 3 mM KCl, 7 mM Na2HPO4, 2 mM
KH2PO4, and 20 mM NaF, pH 7.4). The
pellets were resuspended in 30 µl of 2× Laemmli sample buffer. After
boiling for 5 min, samples were centrifuged, and protein in the
supernatant was analyzed on a 10% SDS-polyacrylamide gel and Western
blotting with anti-Tyr(P) antibody (0.2 µg/ml) and, after stripping,
with anti-dynamin antibody (clone 41; 0.125 µg/ml). Immunoreactivity
was visualized with peroxidase-conjugated goat anti-mouse antibody.
c-Src Immunoprecipitation and c-Src Kinase Activity
Assay--
After serum depletion for 16 h, HEK-293 cells on
150-mm plates stably expressing M1 or M2 mAChRs
(17) were stimulated for 5 min at 37 °C with 100 µM
carbachol in 25 mM HEPES-buffered DMEM/F-12 medium. Then
the medium was rapidly removed from the plates, and the cells were
lysed in 1.5 ml of lysis buffer (10 mM Tris-HCl, pH 7.4, 500 mM NaCl, 10 mM EDTA, 20 mM NaF,
1 mM NaVO4, 1.0% Nonidet P-40, 1 mM dithiothreitol, 2.5 µg/ml leupeptin, 2.5 µg/ml
aprotinin, and 100 µM phenylmethylsulfonyl fluoride).
From this lysate, c-Src was immunoprecipitated with anti-Src antibody
N-16 (1.5 µg) with 50 µl of Protein A Plus/Protein G-agarose beads.
Immunoprecipitates were washed five times with lysis buffer and once in
c-Src kinase buffer (100 mM Tris-HCl, pH 7.4, 125 mM MgCl2, 25 mM MnCl2,
2 mM EGTA, 250 µM NaVO4, 2 mM dithiothreitol), followed by resuspension in 85 µl of
Src kinase buffer with prepared c-Src substrate peptide and
[ Receptor Internalization Assays--
Internalization of mAChRs
was determined 48 h after DNA transfection by
[3H]NMS binding assays to intact cells in 25 mM HEPES-buffered saline, pH 7.4 (HBS), containing 113 mM NaCl, 6 mM glucose, 3 mM KCl, 3 mM MgCl2, 2 mM MgSO4,
and 1 mM NaH2PO4 at 4 °C as
described in detail previously (10). Expression levels of
M1 and M2 mAChRs varied between 100 and 750 fmol/mg of protein. Where indicated, transfected HEK-293 tsA201 cells
were serum-starved for an additional 16 h in DMEM/F-12 medium.
AT1AR internalization was measured following incubation in
25 mM HEPES-buffered DMEM/F-12 medium buffer containing 1 mg/ml BSA with 1 µM unlabeled human angiotensin II
(Sigma) for 60 min at 37 °C. Cells were then washed twice with
ice-cold HBS; twice with ice-cold 20 mM
2-morpholinoethanesulfonic acid, 300 mM NaCl (pH 5.0); and
twice with ice-cold HBS buffer (3 min each) to remove angiotensin II
from receptor. Thereafter, cells were incubated in HBS buffer (with 1 mg/ml BSA) at 4 °C with 4-5 pM [125I]Tyr4-Sar1-Ile8-angiotensin
II with or without 10 µM angiotensin II to determine nonspecific and total binding, respectively. After 4 h, cells were
washed three times with HBS buffer and solubilized in 0.1% Triton
X-100, and radioactivity was counted. Depletion of
[125I]Tyr4-Sar1-Ile8-angiotensin
II was limited to maximally 20% of total added radioligand by the
inclusion of 4 nM unlabeled angiotensin II. Receptor
internalization is expressed as (1 Subcellular Redistribution of M2 mAChR in HEK-293 Cells
in Response to Carbachol--
Internalization of M2 mAChRs
in HEK-293 cells was monitored by indirect immunofluorescence of
M2 mAChRs tagged with a c-Myc epitope at the extracellular
amino terminus. For this, we used stably M2
mAChR-expressing cells instead of transiently expressing HEK-293 tsA201
cells. In the latter cell type, there was a significant preexisting
intracellular pool of M2 mAChRs that did not permit unequivocal demonstration of receptor translocation from the plasma membrane into the cytosol upon carbachol treatment. Control
[3H]NMS binding experiments demonstrated that the
Myc-tagged M2 mAChRs sequestered with similar
characteristics as the wild-type M2 mAChRs in either
HEK-293 tsA201 or HEK-293 cells (data not shown). As shown in Fig.
1A, M2 mAChRs in
untreated cells were found predominantly at the cell surface. During 60 min of incubation with 1 mM carbachol, M2
mAChRs translocated into the cytoplasm (Fig. 1B). These
results indicate that M2 mAChRs like M1 mAChRs (18) internalize into the cell interior of HEK-293 cells.
Effect of N272 Dynamin on M1-M4 mAChR
Internalization in HEK-293 Cells--
To investigate the role of
dynamin in M2 mAChR internalization, N-terminal deletion
dynamin-1 mutant N272 was expressed with either M1 or
M2 mAChR in HEK-293 tsA201 cells. Fig.
2 shows the overexpression of the various
transfected dynamin constructs used in this study. Expression of all
dynamin forms (with the exception of N272 dynamin) was determined with
a dynamin antibody recognizing the N-terminal part of dynamin-1 and
dynamin-2. N272 dynamin-1, which migrates with an apparent molecular
mass of ~72 kDa instead of ~100 kDa, lacks the greater part of this
antibody-binding epitope. Expression of N272 dynamin was therefore
detected by a dynamin-1 antibody that specifically recognizes a
C-terminal domain of dynamin-1. Fig. 3
shows the effect of expression of N272 dynamin on M1 and M2 mAChR internalization in HEK-293 tsA201 cells.
Expression of N272 dynamin inhibited internalization of M1
and M2 mAChRs in response to receptor stimulation with 100 µM or 10 µM carbachol for 60 min by 68 and
55%, respectively. Also, sequestration of M3 and
M4 mAChRs in response to 100 or 10 µM
carbachol for 60 min was reduced from 20 ± 5 to 1 ± 1% and
from 35 ± 3 to 12 ± 4%, respectively, by co-expression of
N272 dynamin in HEK-293 tsA201 cells (n = 3 experiments; data not shown). In contrast, as reported earlier by us
(10) and others (12), expression of K44A dynamin inhibited
M1 but not M2 mAChR internalization (Fig.
3).
Role of c-Src in Dynamin-mediated mAChR Internalization in HEK-293
Cells--
The results presented above strongly suggested that dynamin
is not only required for internalization of M1,
M3, and M4 mAChRs but also essential for
M2 mAChR internalization in HEK-293 tsA201 cells. We
therefore set out to analyze whether dynamin function in the
M1 and M2 mAChR internalization pathways is
differentially regulated. Recently, it was reported that
internalization of Effect of K535M Dynamin on M1-M4 mAChR
Internalization in HEK-293 Cells--
Since PIP2 has
recently been implicated as an important regulator of dynamin function
(6-9), we tested the role of PIP2 binding in
dynamin-mediated mAChR internalization by coexpression of K535M dynamin. Western blot analysis of K535M dynamin expression is shown in
Fig. 2. As depicted in Fig. 6, expression
of K535 dynamin inhibited internalization of M1 and
M2 mAChRs by 64 and 73%, respectively. Carbachol-induced
internalization of M3 and M4 mAChRs was
inhibited to a similar extent by expression of K535M dynamin
(n = 3 experiments; data not shown).
Effect of N272 and K535M Dynamin on AT1AR
Internalization in HEK-293 Cells--
Since internalization of
AT1ARs in HEK-293 cells has been previously reported to be
insensitive to overexpression of K44A dynamin (13), we also determined
whether N272 dynamin or K535M dynamin blocks AT1AR
internalization in HEK-293 tsA201 cells. As shown in Fig.
7, expression of N272 dynamin and K535M
dynamin inhibited AT1AR internalization by 63 and
71%, respectively. In accordance with the aforementioned study on
AT1AR internalization (13), expression of K44A dynamin did
not affect AT1AR internalization (Fig. 7).
In the past few years, the question whether dynamin plays an
essential role in the internalization of a particular GPCR has been
mostly analyzed by using K44A dynamin as dominant-negative mutant.
While internalization of most GPCRs is blocked by expression of K44A
dynamin, some GPCRs like the M2 mAChRs, D2
dopamine receptors, secretin receptors, and AT1ARs
internalize irrespective of K44A dynamin expression, suggesting that
internalization of these GPCRs is dynamin-independent (10, 12-15). We
now report that, contrary to what is currently postulated,
internalization of M2 mAChR and AT1AR is
dynamin-dependent. Coexpression of the dominant-negative dynamin mutants N272 and K535M strongly inhibited M2 mAChR
and AT1AR internalization in HEK-293 tsA201 cells. These
findings imply that N272 and K535M dynamin are more appropriate
dominant-negative dynamin mutants than K44A dynamin. In this context,
it will be interesting to determine whether fluid-phase endocytosis (5, 20) and internalization of ricin (21) are affected by expression of
N272 or K535M dynamin also, because these trafficking processes are not
blocked by K44A dynamin and are thus considered to be dynamin-independent. It is intriguing that N272 dynamin, which lacks
all three GTP-binding motifs, inhibits internalization of both
M1 and M2 mAChR, while K44A dynamin, which
lacks only the first GTP-binding motif, blocks only M1
mAChR internalization. It is possible that K44A dynamin selectively
sequesters away an essential component of the M1 but not of
the M2 mAChR internalization pathway. Another potential
explanation relates to the fact that K44A dynamin is able to coassemble
with wild-type dynamin (22). Since dynamin assembly and interaction of
dynamin with other proteins requires the C terminus of the dynamin,
which varies among the dynamin isoforms (23), different internalization
pathways may use different dynamin isoforms. As a result, different
internalization pathways may display differential sensitivity toward
interference of K44A dynamin. Perhaps assembled GTP-bound K44A dynamin
is sufficiently active to catalyze the budding of M2 mAChR-
and AT1AR-containing vesicles from the plasma membrane but
is not able to support internalization of M1 mAChRs in
clathrin-coated vesicles.
In the present study, we observed that mAChR and AT1AR
internalization in HEK-293 cells is strongly inhibited by expression of
K535M dynamin, a dynamin mutant, which lacks the putative
PIP2 binding site (6). At present, it is unknown at which
stage of the vesicle budding process PIP2 binding to
dynamin is essential. It has been postulated that, after recruitment of
dynamin to the clathrin-coated pit, dynamin's interaction with the
plasma membrane is strengthened by the binding of dynamin's pleckstrin
homology domain with PIP2 in the plasma membrane (8). In
addition, PIP2 binding might promote self-assembly of the
dynamin molecules at the neck of the clathrin-coated pit and stimulate
dynamin's GTPase activity (8, 9). An alternative possibility is that
lysine 535 in the pleckstrin homology domain of dynamin serves to
promote interaction of dynamin with proteins rather than with
PIP2 (6). Regardless of the mechanism, our study clearly
underscores the relevance of dynamin's lysine 535 residue in GPCR
internalization. Identification of the binding partners of dynamin's
pleckstrin homology domain will be important for understanding the
mechanisms of GPCR internalization.
In analogy with recent studies on the regulation of internalization of
We thank Riccarda Krudewig and Barbara Langer
for expert technical assistance. We are indebted to Drs. J. P. Albanesi, L. Hein, R. J. Lefkowitz, J. T. Parsons, and S. Schmid for their gift of the various DNA plasmids and Dr. G. Rijksen
for providing anti-Src antibody.
*
This work was supported by a grant from the Deutsche
Forschungsgemeinschaft.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
These authors contributed equally to this work.
¶
To whom correspondence should be addressed: Institut für
Pharmakologie, Universitätsklinikum Essen, Hufelandstr. 55, D-45122 Essen, Germany. Tel.: 49-201-723-3462; Fax: 49-201-723-5968;
E-mail: van_koppen@uni-essen.de.
Published, JBC Papers in Press, May 2, 2000, DOI 10.1074/jbc.M001736200
2
Y. Werbonat, N. Kleutges, K. H. Jakobs, and
C. J. van Koppen, unpublished observations.
The abbreviations used are:
GPCR, G
protein-coupled receptor;
AT1AR, angiotensin
AT1A receptor;
BSA, bovine serum albumin;
mAChR, muscarinic
acetylcholine receptor;
NMS, N-methylscopolamine;
PIP2, phosphatidylinositol 4,5-bisphosphate;
HBS, HEPES-buffered saline;
DMEM, Dulbecco's modified Eagle's
medium.
Essential Role of Dynamin in Internalization of M2
Muscarinic Acetylcholine and Angiotensin AT1A
Receptors*
§,
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-arrestin to the phosphorylated receptor (1).
-Arrestin then sterically inhibits further interaction of the
receptor with heterotrimeric G proteins and binds with high affinity to
clathrin heavy chains (1). Through this interaction, GPCRs are believed
to be targeted to clathrin-coated pits. Following transformation of the
clathrin-coated pit into a clathrin-coated vesicle, the clathrin-coated
vesicle pinches off from the plasma membrane. This process is catalyzed
by the 100-kDa GTPase dynamin, which probably activates (as yet largely
unknown) effectors of the fission machinery (2). Three closely related
mammalian dynamin isoforms have been identified: neuronal dynamin-1,
ubiquitously expressed dynamin-2, and dynamin-3, which is expressed in
testes, neurons, and lung (3). Comparison of the primary sequence shows that all three dynamin isoforms contain three highly conserved GTP-binding motifs (i.e. elements I, II, and III). A
Lys44
Ala substitution in the first of the three
putative GTP-binding motifs yields a dominant-negative dynamin mutant,
which displays strongly impaired GTPase activity and is predicted to
have a greatly reduced GTP binding affinity (4). The two other
GTP-binding motifs in dynamin are likely to be involved in GTP binding
as well. Mutation of the third GTP-binding motif (substitution
Lys206
Asp in element III) or removal of all three
GTP-binding motifs (amino acids 1-271 in dynamin-1) drastically
reduces clathrin-coated vesicle-mediated internalization (4-6). A
second important regulator of dynamin function is phosphatidylinositol
4,5-bisphosphate (PIP2) (6-9). All three dynamin isoforms
contain a pleckstrin homology domain that is able to bind
PIP2. Binding of PIP2 to dynamin not only
strongly increases the GTPase activity of dynamin but may also serve to
target dynamin to the plasma membrane, allowing subsequent dynamin
self-assembly at the neck of the clathrin-coated vesicle (6-9).
Expression of the dynamin mutant K535M, which is not stimulatable by
PIP2, effectively blocks transferrin receptor internalization in clathrin-coated vesicles (6).
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-32P]ATP (3000 Ci/mmol) were
purchased from NEN Life Science Products. PP1 and genistein were
purchased from Biomol and Calbiochem, respectively. The cDNA
constructs encoding wild-type c-Src and K298M c-Src were gifts from Dr.
J. T. Parsons. Rat wild-type dynamin-1aa and rat K535M dynamin-1aa
cDNA in pCMV96-7 (6) were generously provided by Dr. J. P. Albanesi. Rat Y231F,Y597F dynamin-1aa in pCMV96-7 (16) was a gift from
Dr. R. J. Lefkowitz. The mouse AT1AR cDNA in
pBC12BI was a gift from Dr. L. Hein. The cDNAs encoding HA-tagged wild-type and K44A human dynamin-1aa (4) in pRK5 were gifts from Dr. S. Schmid. Rat dynamin-1aa N272 was generated by digestion of rat
wild-type dynamin-1aa in pCMV96-7 with BglII and
EcoRV. The product was filled in with Klenow DNA polymerase
and religated with T4 DNA ligase. The authenticity of the N272 dynamin
mutant was confirmed by dideoxy DNA sequencing and Western blot
analysis. Rabbit anti-c-Src polyclonal antibody (N-16), mouse
anti-Tyr(P) antibody (PY20), and goat anti-dynamin-1 antibody (C-16)
were from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA). Mouse
anti-Myc 9E10 antibody, mouse anti-dynamin antibody (clone 41), and
peroxidase-conjugated goat anti-mouse antibody were obtained from
Calbiochem, Transduction Laboratories, and Dianova, respectively.
Peroxidase-conjugated rabbit anti-goat antibody, peroxidase-conjugated
goat anti-rabbit antibody, and fluorescein isothiocyanate-labeled
anti-mouse antibody were from Sigma.
-32P]ATP (125 µM, 10-20 µCi/vial)
according to the manufacturer's instructions (Upstate Biotechnology,
Inc., Lake Placid, NY). The mixture was incubated at 30 °C for 12 min while shaking, and the reaction was stopped by the addition of 40 µl of 40% trichloroacetic acid. Thirty-microliter aliquots of the
reaction mixture were spotted on P81 phosphocellulose paper in
duplicate, washed five times for 5 min each with 0.75% phosphoric acid
and once with acetone for 3 min, followed by radioactivity counting.
quotient of cell surface
receptors of agonist-treated and untreated cells) × 100%.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (52K):
[in a new window]
Fig. 1.
Visualization of M2 mAChR
internalization in HEK-293 cells by immunofluorescence microscopy.
HEK-293 cells stably expressing Myc-tagged M2 mAChRs were
incubated in the absence (A) and presence (B) of
1 mM carbachol for 60 min at 37 °C, fixed and
permeabilized in methanol, and processed for immunofluorescence for the
Myc-tagged M2 mAChR as described under "Experimental
Procedures." Representative images of six experiments are
shown.

View larger version (29K):
[in a new window]
Fig. 2.
Expression of endogenous dynamin and
transiently expressed dynamin proteins in HEK-293 tsA201 cells.
HEK-293 tsA201 cells were transiently transfected with empty pRK5
(pRK5), pCMV96-7/N272 dynamin (N272 Dyn),
pCMV96-7/wild-type dynamin (WT Dyn), pRK5/K44A dynamin
(K44A Dyn), pCMV96-7/Y231F,Y597F dynamin (Y231,597F
Dyn), or pCMV96-7/K535M dynamin (K535M Dyn). Equal
amounts of total cell lysates (50 µg of protein/lane) were subjected
to SDS-polyacrylamide gel electrophoresis and immunoblotting.
Expression of endogenous dynamin (lane 1), wild-type
dynamin, and the dynamin mutants K44A, K535M, and Y231F,Y597F was
determined using a mouse anti-dynamin monoclonal antibody recognizing
the N terminus of dynamin. N272 dynamin expression was determined using
a rabbit anti-dynamin polyclonal antibody directed against the C
terminus of dynamin-1. Control immunoblot experiments with the rabbit
anti-dynamin polyclonal antibody showed that expression of N272 dynamin
was similar to expression of the other transfected dynamin constructs
(data not shown).

View larger version (21K):
[in a new window]
Fig. 3.
Effects of expression of wild-type dynamin,
N272 dynamin, and K44A dynamin on M1 and M2
mAChR internalization in HEK-293 tsA201 cells. HEK-293 tsA201
cells transiently transfected with pCD-PS/M1 or
M2 mAChR together with empty pRK5 (pRK5),
pCMV96-7/wild-type dynamin (WT Dyn), pCMV96-7/N272 dynamin
(N272 Dyn), or pRK5/K44A dynamin (K44A Dyn) were
incubated with 100 µM (M1 mAChR) or 10 µM (M2 mAChR) carbachol for 60 min.
Internalization of receptors was determined by specific
[3H]NMS binding to intact cells. Cell surface expression
of M1 and M2 mAChRs was not affected by
coexpression of either dynamin construct. Data are the mean ± S.E. of four (M1 mAChR) and six (M2 mAChR)
experiments. *, p < 0.05 compared with
response of empty pRK5 vector-transfected cells (two-tailed
t test).
2-adrenergic receptors in HEK-293
cells requires c-Src-mediated phosphorylation of dynamin on two
tyrosine residues (i.e. Tyr231 and
Tyr597) (16). c-Src is activated by
-arrestin, which is
bound to the agonist-occupied
2-adrenergic receptor and
targets the receptor to the clathrin-coated pit (16). As M1
mAChRs in HEK-293 tsA201 cells internalize into clathrin-coated
vesicles in a
-arrestin-dependent manner (11), we first
investigated the role of c-Src in M1 mAChR internalization
in HEK-293 cells. As shown in Fig.
4A, activation of
M1 mAChRs in HEK-293 cells with 100 µM
carbachol for 5 min increased c-Src kinase activity by 208 ± 16%. Basal and receptor-stimulated c-Src activity was effectively
blocked by treatment with the selective c-Src inhibitor PP1 (1 µM). Stimulation of M1 mAChRs led to an 82 ± 29% increase in tyrosine phosphorylation of endogenously expressed dynamin (Fig. 4B) (mean ± S.E. of four
independent experiments), an increase that is comparable with the
increases observed in other experimental systems (16, 19). As shown in
Fig. 5A, transfection of
HEK-293 tsA201 cells with wild-type c-Src or K298M c-Scr cDNA led
to a strong overexpression of the corresponding c-Src protein over
endogenous c-Src. While the expression of wild-type c-Src had no
effect, the expression of catalytically defective K298M c-Src reduced
M1 mAChR internalization by 52% (Fig. 5B). Also, expression of Y231F,Y597F dynamin, which cannot be
tyrosine-phosphorylated by c-Src (16), inhibited M1 mAChR
internalization by 76% (Fig. 5B). In contrast, expression
of a catalytically defective mutant of another tyrosine kinase, Pyk2
(K457A), did not affect M1 mAChR internalization (data not
shown). Like M1 mAChRs, M2 mAChRs stimulate c-Src activity in HEK-293 cells, albeit to a smaller extent than M1 mAChRs (i.e. 78 ± 34%) (Fig.
4A). However, expression of K298M c-Src did not inhibit
M2 mAChR internalization, while expression of Y231F,Y597F
dynamin slightly reduced M2 mAChR internalization. These
results are supported by the observation that M2 mAChR
internalization in HEK-293 tsA201 cells was not inhibited by
pretreatment of the cells with PP1 (10 µM), while the
generic tyrosine kinase inhibitor genistein (100 µM)
inhibited M2 mAChR internalization by 16% (Table I). In contrast, internalization of
M1 mAChRs was reduced by 41 and 48% following treatment of
the cells with 10 µM PP1 or 100 µM
genistein, respectively (Table I).

View larger version (25K):
[in a new window]
Fig. 4.
mAChR-induced activation of c-Src and
tyrosine phosphorylation of dynamin in HEK-293 cells.
A, HEK-293 cells stably expressing M1 or
M2 mAChRs and serum-starved overnight were stimulated
without (Con) and with 100 µM carbachol
(Car) for 5 min. Src kinase was immunoprecipitated from cell
lysates, and c-Src kinase activity was determined with
[
-32P]ATP and Src substrate peptide. PP1 (1 µM) was included in the reaction mixture where indicated
15 min before the addition of [
-32P]ATP. The presence
of dimethyl sulfoxide as vehicle (final concentration of 0.01%) did
not affect c-Src activity. Data are the mean ± S.E. of four
(M1 mAChR) or six (M2 mAChR) experiments.
B, HEK-293 cells stably expressing M1 mAChRs
were stimulated without (Con) and with 100 µM
carbachol (Car) for 5 min after serum starvation overnight.
Dynamin immunoprecipitates (IP) were subjected to
SDS-polyacrylamide gel electrophoresis, and tyrosine phosphorylation of
dynamin was detected by immunoblotting (IB) with
anti-phosphotyrosyl antibody (upper panel). The filter shown
in the upper panel was stripped and blotted with
anti-dynamin antibody to document equivalent dynamin loading
(lower panel). Similar images were obtained in three other
experiments.

View larger version (30K):
[in a new window]
Fig. 5.
Effects of expression of wild-type
c-Src, K298M c-Src, wild-type dynamin and Y231F,Y597F dynamin on
M1 and M2 mAChR internalization in HEK-293
tsA201 cells. A, detection of c-Src expression in total
lysates of control transfected HEK-293 tsA201 cells (pRK5)
and cells overexpressing wild-type c-Src (WT Src) or K298M
c-Src (K298M Src). Lane 1 (pRK5) shows
expression level of endogenous c-Src. B, HEK-293 tsA201
cells transiently expressing M1 or M2 mAChR
together with control vector (pRK5), wild-type Src (WT
Src), K298M c-Src (K298M Src), wild-type dynamin
(WT Dyn), or Y231F,Y597F dynamin (Y231,597F Dyn)
were incubated with 100 µM (M1 mAChR) or 10 µM (M2 mAChR) carbachol for 60 min.
Internalization of receptors was determined by specific
[3H]NMS binding to intact cells. Data are the mean ± S.E. of five (M1 mAChRs) and six (M2 mAChRs)
experiments each. *, p < 0.05 compared with response
of empty pRK5 vector-transfected cells (two-tailed t
test).
Effect of PP1 and genistein on M1 and M2 mAChR
internalization in HEK-293 tsA201 cells

View larger version (18K):
[in a new window]
Fig. 6.
Effects of expression of wild-type dynamin
and K535M dynamin on M1 and M2 mAChR
internalization in HEK-293 tsA201 cells. HEK-293 tsA201 cells
transiently transfected with pCD-PS/M1 mAChR or
pCD-PS/M2 mAChR together with empty pRK5 (pRK5),
pCMV96-7/wild-type dynamin (WT Dyn), or pCMV96-7/K535M
dynamin (K535M Dyn) were incubated with 100 µM
(M1 mAChR) or 10 µM (M2 mAChR)
carbachol for 60 min. Internalization of receptors was determined by
specific [3H]NMS binding to intact cells. Cell surface
expression of M1 and M2 mAChRs was not affected
by coexpression of either dynamin construct. Data are the mean ± S.E. of nine (M1 mAChRs) and 13 (M2 mAChRs)
sets of experiments. *, p < 0.05 compared
with response of empty pRK5 vector-transfected cells (two-tailed
t test).

View larger version (26K):
[in a new window]
Fig. 7.
Effects of expression of wild-type dynamin
and the dynamin mutants K44A, N272, and K535M on AT1AR
internalization in HEK-293 tsA201 cells. HEK-293 tsA201 cells
transiently transfected with AT1AR/pBC12BI together with
empty pRK5 (pRK5), pCMV96-7/wild-type dynamin (WT
Dyn), pRK5/K44A dynamin (K44A Dyn), pCMV96-7/N272
dynamin (N272 Dyn), or pCMV96-7/K535M dynamin (K535M
Dyn) were incubated with 1 µM angiotensin II for 60 min. Internalization of receptors was determined by specific
[125I]Tyr4-Sar1-Ile8-angiotensin
II binding to intact cells as described under "Experimental
Procedures." Total and nonspecific binding of
[125I]Tyr4-Sar1-Ile8-angiotensin
II varied between 1700 and 4000 and between 50 and 180 cpm/well of a
24-well plate, respectively. Data are the mean ± S.E. of four
experiments. *, p < 0.05 compared with
response of empty pRK5 vector-transfected cells (two-tailed
t test).
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
2-adrenergic receptors in HEK-293 cells (16, 24), we
show that internalization of M1 mAChRs is strongly reduced by inhibition of c-Src activity and by overexpression of
Y231F,Y597F dynamin, which cannot be phosphorylated by c-Src.
Since M1 mAChRs internalize in clathrin-coated vesicles in
a
-arrestin-dependent manner, we propose that, in
analogy to
2-adrenergic receptors, internalization of
M1 mAChRs involves
-arrestin-mediated targeting of
receptor in the clathrin-coated pit and activation of c-Src by
-arrestin. c-Src then phosphorylates dynamin, a process that is
required for M1 mAChR internalization in HEK-293 cells.
Whether tyrosine phosphorylation activates dynamin or allows activation of dynamin by other molecules remains to be determined. In contrast, dynamin-mediated internalization of M2 mAChRs was found not
to be inhibited by expression of kinase-defective K298M c-Src or treatment of the cells with the specific c-Src inhibitor PP1. Thus,
c-Src does not play a role in M2 mAChR internalization. These findings are supported by recent studies showing that
M2 mAChR internalization in HEK-293 cells is
-arrestin-independent (11, 12). However, treatment of the cells with
the generic tyrosine kinase, genistein, or coexpression of Y231F,Y597F
dynamin did slightly reduce M2 mAChR internalization. This
suggests that M2 mAChR internalization is regulated to a
very limited extent by phosphorylation of dynamin by tyrosine kinases
other than c-Src. On the basis of the present and previous findings
(11), we propose that M2 mAChR internalization in HEK-293
cells is catalyzed by a dynamin isoform that differs from the dynamin
isoform involved in clathrin-mediated M1 mAChR
internalization. Much remains to be learned about the internalization
pathway of M2 mAChR (and AT1AR) in HEK-293
cells. We have observed that pretreatment of HEK-293 cells with 0.45 M sucrose fully blocks M2 (and M1)
mAChR internalization in HEK-293
cells.2 Yet expression of a
dominant-negative clathrin mutant or
-arrestin V53D, which inhibits
clathrin-mediated internalization of GPCRs, blocks M1 but
not M2 mAChR internalization (11). Similarly, expression of
the amphiphysin SH3 domain, which blocks the targeting of dynamin to
clathrin-coated pits, inhibits M1 but not M2
mAChR internalization in HEK-293 cells.2 On the basis of
these findings, we conclude that M2 mAChR internalization in HEK-293 cells is clathrin-independent and that the inhibitory effect
of sucrose on receptor internalization is not specific for
clathrin-mediated internalization. In this respect, it is important to
note that hypertonic sucrose treatment of HEK-293 cells does not only
block vesicle formation at the plasma membrane but may also induce
other cellular responses including MAP kinase activation (25), which
may inhibit receptor internalization indirectly (26). Interestingly,
similar findings have been obtained recently with the secretin
receptor. Internalization of secretin receptors in HEK-293 cells is
unaffected by expression of dynamin K44A and
-arrestin V53D but is
sensitive to sucrose pretreatment (15). Presently, it is unknown
through which vesicles AT1AR internalizes in HEK-293 cells.
In adrenal glomerulosa and Chinese hamster ovary cells,
AT1AR may internalize through clathrin-coated vesicles,
although this has only been inferred from biochemical (and not
morphological) experiments using hypertonic sucrose treatment or
potassium depletion (27). In vascular smooth muscle cells, however,
AT1ARs have been found to internalize through noncoated pits, possibly caveolae, as well as coated pits (27, 28). Thus,
the internalization of AT1AR and other GPCRs (10) appears to differ among different cell types. The identification of the budding
vesicles through which AT1AR and M2 mAChR
internalize in HEK-293 cells and other cell types will provide
important information on the molecular mechanisms of GPCR internalization.
![]()
ACKNOWLEDGEMENTS
![]()
FOOTNOTES
Supported by an IFORES predoctoral fellowship from the
Universitätsklinikum Essen.
![]()
ABBREVIATIONS
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1.
Goodman, O. B., Jr.,
Krupnick, J. G.,
Santini, F.,
Gurevich, V. V.,
Penn, R. B.,
Gagnon, A. W.,
Keen, J. H.,
and Benovic, J. L.
(1996)
Nature
383,
447-450
2.
Sever, S.,
Muhlberg, A. B.,
and Schmid, S. L.
(1999)
Nature
398,
481-486
3.
Schmid, S. L.,
McNiven, M. A.,
and De Camilli, P.
(1998)
Curr. Opin. Cell Biol.
10,
504-512
4.
Van der Bliek, A. M.,
Redelmeier, T. E.,
Damke, H.,
Tisdale, E. J.,
Meyerowitz, E. M.,
and Schmid, S. L.
(1993)
J. Cell Biol.
122,
553-563
5.
Herskovits, J. S.,
Burgess, C. C.,
Obar, R. A.,
and Vallee, R. B.
(1993)
J. Cell Biol.
122,
565-578
6.
Achiriloaie, M.,
Barylko, B.,
and Albanesi, J. P.
(1999)
Mol. Cell. Biol.
19,
1410-1415
7.
Lin, H. C.,
and Gilman, A. G.
(1996)
J. Biol. Chem.
271,
27979-27982
8.
Barylko, B.,
Binns, D.,
Lin, K.-M.,
Atkinson, M. A. L.,
Jameson, D. M.,
Yin, H. L.,
and Albanesi, J. P.
(1998)
J. Biol. Chem.
273,
3791-3797
9.
Klein, D. E.,
Lee, A.,
Frank, D. W.,
Marks, M. S.,
and Lemmon, M. A.
(1998)
J. Biol. Chem.
273,
27725-27733
10.
Vögler, O.,
Bogatkewitsch, G. S.,
Wriske, C.,
Krummenerl, P.,
Jakobs, K. H.,
and Van Koppen, C. J.
(1998)
J. Biol. Chem.
273,
12155-12160
11.
Vögler, O.,
Nolte, B.,
Voss, M.,
Schmidt, M.,
Jakobs, K. H.,
and Van Koppen, C. J.
(1999)
J. Biol. Chem.
274,
12333-12338
12.
Pals-Rylaarsdam, R.,
Gurevich, V. V.,
Lee, K. B.,
Ptasiensky, J. A.,
Benovic, J. L.,
and Hosey, M. M.
(1997)
J. Biol. Chem.
272,
23682-23689
13.
Zhang, J.,
Ferguson, S. S. G.,
Barak, L. S.,
Ménard, L.,
and Caron, M. G.
(1996)
J. Biol. Chem.
271,
18302-18305
14.
Vickery, R. G.,
and von Zastrow, M.
(1999)
J. Cell Biol.
144,
31-43
15.
Walker, J. K. L.,
Premont, R. T.,
Barak, L. S.,
Caron, M. G.,
and Shetzline, M. A.
(1999)
J. Biol. Chem.
274,
31515-31523
16.
Ahn, S.,
Maudsley, S.,
Luttrell, L. M.,
Lefkowitz, R. J.,
and Daaka, Y.
(1999)
J. Biol. Chem.
274,
1185-1188
17.
Peralta, E. G.,
Ashkenazi, A.,
Winslow, J. W.,
Ramachandran, J.,
and Capon, D. J.
(1988)
Nature
334,
434-437
18.
Tolbert, L. M.,
and Lameh, J.
(1996)
J. Biol. Chem.
271,
17335-17342
19.
Kranenburg, O.,
Verlaan, I.,
and Moolenaar, W. H.
(1999)
Biochem. J.
339,
11-14
20.
Damke, H.,
Baba, T.,
Warnock, D. E.,
and Schmid, S. L.
(1994)
J. Cell Biol.
127,
915-934
21.
Simpson, J. C.,
Smith, D. C.,
Roberts, L. M.,
and Lord, J. M.
(1998)
Exp. Cell Res.
239,
293-300
22.
Warnock, D. E.,
Hinshaw, J. E.,
and Schmid, S. L.
(1996)
J. Biol. Chem.
271,
22310-22314
23.
Smirnova, E.,
Shurland, D.-L.,
Newman-Smith, E. D.,
Pishvaee, B.,
and Van der Bliek, A. M.
(1999)
J. Biol. Chem.
274,
14942-14947
24.
Luttrell, L. M.,
Ferguson, S. S. G.,
Daaka, Y.,
Miller, W. E.,
Maudsley, S.,
Della Rocca, G. J.,
Lin, F.-T.,
Kawakatsu, H.,
Owada, K.,
Luttrell, D. K.,
Caron, M. G.,
and Lefkowitz, R. J.
(1999)
Science
283,
655-661
25.
Schramm, N. L.,
and Limbird, L. E.
(1999)
J. Biol. Chem.
274,
24935-24940
26.
Pitcher, J. A.,
Tesmer, J. J. G.,
Freeman, J. L. R.,
Capel, W. D.,
Stone, W. C.,
and Lefkowitz, R. J.
(1999)
J. Biol. Chem.
274,
34531-34534
27.
Hunyady, L.
(1999)
J. Am. Soc. Nephrol.
10,
S47-S56
28.
Ishizaka, N.,
Griendling, K. K.,
Lassègue, B.,
and Alexander, R. W.
(1998)
Hypertension
32,
459-466
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
O. Destaing, A. Sanjay, C. Itzstein, W. C. Horne, D. Toomre, P. De Camilli, and R. Baron The Tyrosine Kinase Activity of c-Src Regulates Actin Dynamics and Organization of Podosomes in Osteoclasts Mol. Biol. Cell, January 1, 2008; 19(1): 394 - 404. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Fessart, M. Simaan, B. Zimmerman, J. Comeau, F. F. Hamdan, P. W. Wiseman, M. Bouvier, and S. A. Laporte Src-dependent phosphorylation of beta2-adaptin dissociates the beta-arrestin-AP-2 complex J. Cell Sci., May 15, 2007; 120(10): 1723 - 1732. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. T. Yamanushi, Z. Shui, R. N. Leach, H. Dobrzynski, T. W. Claydon, and M. R. Boyett Role of internalization of M2 muscarinic receptor via clathrin-coated vesicles in desensitization of the muscarinic K+ current in heart Am J Physiol Heart Circ Physiol, April 1, 2007; 292(4): H1737 - H1746. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Ashton and Y. A. Ushkaryov Properties of Synaptic Vesicle Pools in Mature Central Nerve Terminals J. Biol. Chem., November 4, 2005; 280(44): 37278 - 37288. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. R. Chin and M. S. Horwitz Mechanism for Removal of Tumor Necrosis Factor Receptor 1 from the Cell Surface by the Adenovirus RID{alpha}/{beta} Complex J. Virol., November 1, 2005; 79(21): 13606 - 13617. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. N. Becker, H.-f. Cheng, T. G. Hammond, and R. C. Harris The Type 1 Angiotensin II Receptor Tail Affects Receptor Targeting, Internalization, and Membrane Fusion Properties Mol. Pharmacol., February 1, 2004; 65(2): 362 - 369. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Perron, Z.-g. Chen, D. Gingras, D. J. Dupre, J. Stankova, and M. Rola-Pleszczynski Agonist-independent Desensitization and Internalization of the Human Platelet-activating Factor Receptor by Coumermycin-Gyrase B-induced Dimerization J. Biol. Chem., July 18, 2003; 278(30): 27956 - 27965. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Herring, R. Huang, M. Singh, L. C. Robinson, G. H. Dillon, and N. J. Leidenheimer Constitutive GABAA Receptor Endocytosis Is Dynamin-mediated and Dependent on a Dileucine AP2 Adaptin-binding Motif within the {beta}2 Subunit of the Receptor J. Biol. Chem., June 20, 2003; 278(26): 24046 - 24052. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Fourgeaud, A.-S. Bessis, F. Rossignol, J.-P. Pin, J.-C. Olivo-Marin, and A. Hemar The Metabotropic Glutamate Receptor mGluR5 Is Endocytosed by a Clathrin-independent Pathway J. Biol. Chem., March 28, 2003; 278(14): 12222 - 12230. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Delaney, M. M. Murph, L. M. Brown, and H. Radhakrishna Transfer of M2 Muscarinic Acetylcholine Receptors to Clathrin-derived Early Endosomes following Clathrin-independent Endocytosis J. Biol. Chem., August 30, 2002; 277(36): 33439 - 33446. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ahn, J. Kim, C. L. Lucaveche, M. C. Reedy, L. M. Luttrell, R. J. Lefkowitz, and Y. Daaka Src-dependent Tyrosine Phosphorylation Regulates Dynamin Self-assembly and Ligand-induced Endocytosis of the Epidermal Growth Factor Receptor J. Biol. Chem., July 12, 2002; 277(29): 26642 - 26651. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Shetzline, J. K. L. Walker, K. J. Valenzano, and R. T. Premont Vasoactive Intestinal Polypeptide Type-1 Receptor Regulation. DESENSITIZATION, PHOSPHORYLATION, AND SEQUESTRATION J. Biol. Chem., July 5, 2002; 277(28): 25519 - 25526. [Abstract] [Full Text] [PDF] |
||||